2023

    1. Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging. Robinson D, Abdulkareem R, Nasrollah D, Ljung A, Hintze P, Wallby S, Ståhlbrandt H, Frennvall T, Styrke J, Stattin P, Garmo H. JAMA Netw Open. 2023 Aug.                       Sammanfattning Fulltext
    2. Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study. Shore R, Zhang J, Ye W, Stattin P, Lindblad M. Cancer Causes Control. 2023 Jun. Sammanfattning. Fulltext
    3. Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study. Crump C, Stattin P, Brooks JD, Sundquist J, Bill-Axelson A, Edwards AC, Sundquist K, Sieh W. Eur Urol. 2023 May. Sammanfattning.
    4. Jochems SHJ, Fritz J, Häggström C, Stattin P, Stocks T. Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study. Cancer Med. 2023 April. Sammanfattning. Fulltext
    5. Garcia-Albeniz X, Stattin P, Westerberg M, Weinrib R, Sandstrom P, Vassilev Z. Design Considerations for Observational Studies of Drugs for Advanced Cancer. Pharmacoepidemiol Drug Saf. 2023 Mar. Sammanfattning.
    6. Westerberg M. Estimation in discrete time coarsened multivariate longitudinal models. Stat Methods Med Res. 2023 Feb. Sammanfatting. Fulltext
    7. George G, Garmo H, Adolfsson J, Elf K, Gedeborg R, Holmberg L, Stattin P, Styrke J, Van Hemelrijck M. Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden. J Oncol. 2023 Feb. Sammanfattning. Fulltext
    8. Sun M, Fritz J, Häggström C, Bjørge T, Nagel G, Manjer J, Engeland A, Zitt E, van Guelpen B, Stattin P, Ulmer H, Stocks T. Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study. J National Cancer Institute. 2023 Jan. Sammanfattning. Fulltext